🔗 Permalink

Inventor profile of:

Peter Smith

City:

Arlington, Massachusetts

Country:

United States

Published Applications:

34

Last publication date:

2026-03-05

Top Assignees for applications by Peter Smith

The entities that hold a legal rights for patent applications filed by inventor Smith Peter:

EISAI R&D MANAGEMENT CO., LTD. 7 Tokyo, Japan
REMIX THERAPEUTICS INC. 1 Cambridge, MA United States

Recent patent applications by Smith Peter

Peter Smith from Arlington, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-03-05

US20260062699A1

Chemistry; metallurgy

METHODS AND COMPOSITIONS FOR MODULATING SPLICING AT ALTERNATIVE SPLICE SITES

#2 | 2025-10-30

US20250333397A1

Chemistry; metallurgy

COMPOUNDS AND METHODS FOR MODULATING SPLICING

#3 | 2025-10-30

US20250332173A1

Human necessities

COMPOUNDS AND METHODS FOR MODULATING NUCLEIC ACID SPLICING

#4 | 2025-10-23

US20250326748A1

Chemistry; metallurgy

COMPOUNDS AND METHODS FOR MODULATING SPLICING

#5 | 2025-05-15

US20250154169A1

Chemistry; metallurgy

COMPOUNDS AND METHODS FOR MODULATING SPLICING

#6 | 2025-05-01

US20250135017A1

Human necessities

SPLICING MODULATOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE

#7 | 2025-04-03

US20250109140A1

Chemistry; metallurgy

5-[5-(PIPERIDIN-4-YL)THIENO[3,2-C]PYRAZOL-2-YL]INDAZOLE DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS FOR SPLICING NUCLEIC ACIDS AND FOR THE TREATMENT OF PROLIFERATIVE DISEASES

#8 | 2025-03-20

US20250092065A1

Chemistry; metallurgy

2-(INDAZOL-5-YL)-6-(PIPERIDIN-4-YL)-1,7-NAPHTHYRIDINE DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS FOR SPLICING NUCLEIC ACIDS AND FOR THE TREATMENT OF PROLIFERATIVE DISEASES

#9 | 2025-03-13

US20250082633A1

Human necessities

COMPOUNDS AND METHODS FOR MODULATING SPLICING

#10 | 2024-12-12

US20240409536A1

Chemistry; metallurgy

COMPOUNDS AND METHODS FOR MODULATING SPLICING

#11 | 2024-12-05

US20240400584A1

Chemistry; metallurgy

COMPOUNDS AND METHODS FOR MODULATING SPLICING

#12 | 2024-11-07

US20240368163A1

Chemistry; metallurgy

COMPOUNDS AND METHODS FOR MODULATING SPLICING

#13 | 2024-11-07

US20240366612A1

Human necessities

COMPOUNDS AND METHODS FOR MODULATING NUCLEIC ACID SPLICING

#14 | 2024-10-31

US20240360108A1

Chemistry; metallurgy

SPLICING MODULATOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE

#15 | 2024-08-29

US20240287097A1

Chemistry; metallurgy

COMPOUNDS AND METHODS FOR MODULATING SPLICING

#16 | 2024-08-22

US20240279239A1

Chemistry; metallurgy

COMPOUNDS AND METHODS FOR MODULATING SPLICING

#17 | 2024-07-18

US20240239811A1

Chemistry; metallurgy

5-(5-(PIPERIDIN-4-YL)THIENO[3,2-C]PYRAZOL-2-YL]INDAZOLE DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS FOR SPLICING NUCLEIC ACIDS AND FOR THE T

#18 | 2024-07-11

US20240226098A1

Human necessities

COMPOUNDS AND METHODS FOR MODULATING SPLICING

#19 | 2024-06-13

US20240190879A1

Chemistry; metallurgy

FUSED BICYCLIC COMPOUNDS USEFUL FOR MODULATING NUCLEIC ACID SPLICING

#20 | 2024-01-18

US20240018522A1

Chemistry; metallurgy

OLIGONUCLEOTIDES USEFUL FOR MODULATION OF SPLICING

#21 | 2024-01-04

US20240002375A1

Chemistry; metallurgy

2-(INDAZOL-5-YL)-6-(PIPERIDIN-4-YL)-1,7-NAPHTHYRIDINE DERIVATIVES AND RELATED COMPOUNDS AS MODULATORS FOR SPLICING NUCLEIC ACIDS AND FOR THE TRE

#22 | 2023-11-16

US20230365566A1

Chemistry; metallurgy

HETEROCYCLIC AMIDES AND THEIR USE FOR MODULATING SPLICING

#23 | 2023-11-16

US20230365526A1

Chemistry; metallurgy

PYRIDAZINE DERIVATIVES FOR MODULATING NUCLEIC ACID SPLICING

#24 | 2023-06-01

US20230167093A1

Chemistry; metallurgy

COMPOUNDS AND METHODS FOR MODULATING SPLICING

#25 | 2023-05-25

US20230159496A1

Chemistry; metallurgy

COMPOUNDS AND METHODS FOR MODULATING SPLICING

#26 | 2023-05-11

US20230148184A1

Chemistry; metallurgy

COMPOUNDS AND METHODS FOR MODULATING SPLICING

#27 | 2023-05-11

US20230142338A1

Chemistry; metallurgy

THIOPHENYL DERIVATIVES USEFUL FOR MODULATING NUCLEIC ACID SPLICING

#28 | 2023-05-11

US20230140983A1

Chemistry; metallurgy

PYRIDAZINE DERIVATIVES FOR MODULATING NUCLEIC ACID SPLICING

#29 | 2022-12-01

US20220380352A1

Chemistry; metallurgy

Splicing modulator antibody-drug conjugates and methods of use

#30 | 2021-09-30

US20210299269A1

Human necessities

Splicing modulator antibody-drug conjugates and methods of use

#31 | 2021-04-08

US20210101888A1

Chemistry; metallurgy

Splicing modulator antibody-drug conjugates and methods of use

#32 | 2020-11-19

US20200360371A1

Human necessities

Combination therapies for the treatment of hepatocellular carcinoma

#33 | 2019-06-13

US20190175598A1

Human necessities

COMBINATION THERAPIES FOR THE TREATMENT OF HEPATOCELLULAR CARCINOMA

#34 | 2019-04-25

US20190117640A1

Human necessities

Drug combinations for reducing cell viability and/or cell proliferation

InventorID:

2525659 ⎘